229 related articles for article (PubMed ID: 24825427)
61. Epidermal growth factor-containing fibulin-like extracellular matrix protein 1 expression and regulation in uterine leiomyoma.
Marsh EE; Chibber S; Wu J; Siegersma K; Kim J; Bulun S
Fertil Steril; 2016 Apr; 105(4):1070-5. PubMed ID: 26702771
[TBL] [Abstract][Full Text] [Related]
62. Oxytocin-induced cell growth proliferation in human myometrial cells and leiomyomas.
Busnelli M; Rimoldi V; Viganò P; Persani L; Di Blasio AM; Chini B
Fertil Steril; 2010 Oct; 94(5):1869-74. PubMed ID: 20056210
[TBL] [Abstract][Full Text] [Related]
63. Tranilast Inhibits Genes Functionally Involved in Cell Proliferation, Fibrosis, and Epigenetic Regulation and Epigenetically Induces miR-29c Expression in Leiomyoma Cells.
Chuang TD; Khorram O
Reprod Sci; 2017 Sep; 24(9):1253-1263. PubMed ID: 28114878
[TBL] [Abstract][Full Text] [Related]
64. The expression of Abl interactor 2 in leiomyoma and myometrium and regulation by GnRH analogue and transforming growth factor-beta.
Luo X; Levens E; Williams RS; Chegini N
Hum Reprod; 2006 Jun; 21(6):1380-6. PubMed ID: 16488906
[TBL] [Abstract][Full Text] [Related]
65. Development and Validation of Hormonal Impact of a Mouse Xenograft Model for Human Uterine Leiomyoma.
Malik M; Britten J; Catherino WH
Reprod Sci; 2020 Jun; 27(6):1304-1317. PubMed ID: 32016804
[TBL] [Abstract][Full Text] [Related]
66. [Influence of recombinant transforming growth factor-beta3 on collagen synthesis and deposition: experiment with rat cell model of liver fibrosis].
Li Q; Zhou X; Yu J; Qian W; Xu KS
Zhonghua Yi Xue Za Zhi; 2008 May; 88(18):1273-8. PubMed ID: 18844103
[TBL] [Abstract][Full Text] [Related]
67. Progesterone receptor modulator CDB-2914 induces extracellular matrix metalloproteinase inducer in cultured human uterine leiomyoma cells.
Xu Q; Ohara N; Liu J; Amano M; Sitruk-Ware R; Yoshida S; Maruo T
Mol Hum Reprod; 2008 Mar; 14(3):181-91. PubMed ID: 18216291
[TBL] [Abstract][Full Text] [Related]
68. Leiomyoma primary cultures have elevated transcriptional response to estrogen compared with autologous myometrial cultures.
Andersen J; DyReyes VM; Barbieri RL; Coachman DM; Miksicek RJ
J Soc Gynecol Investig; 1995; 2(3):542-51. PubMed ID: 9420857
[TBL] [Abstract][Full Text] [Related]
69. Simvastatin ameliorates altered mechanotransduction in uterine leiomyoma cells.
Afrin S; Islam MS; Patzkowsky K; Malik M; Catherino WH; Segars JH; Borahay MA
Am J Obstet Gynecol; 2020 Nov; 223(5):733.e1-733.e14. PubMed ID: 32417359
[TBL] [Abstract][Full Text] [Related]
70. FKBP51 Contributes to Uterine Leiomyoma Pathogenesis by Inducing Cell Proliferation and Extracellular Matrix Deposition.
New EP; Semerci N; Ozmen A; Guo X; Jonnalagadda VA; Kim JW; Anderson ML; Guzeloglu-Kayisli O; Imudia AN; Lockwood CJ; Kayisli UA
Reprod Sci; 2022 Jun; 29(6):1939-1949. PubMed ID: 35426036
[TBL] [Abstract][Full Text] [Related]
71. Inhibition of tumor cell proliferation in human uterine leiomyomas by vitamin D via Wnt/β-catenin pathway.
Corachán A; Ferrero H; Aguilar A; Garcia N; Monleon J; Faus A; Cervelló I; Pellicer A
Fertil Steril; 2019 Feb; 111(2):397-407. PubMed ID: 30458994
[TBL] [Abstract][Full Text] [Related]
72. 1,25-dihydroxyvitamin d3 reduces extracellular matrix-associated protein expression in human uterine fibroid cells.
Halder SK; Osteen KG; Al-Hendy A
Biol Reprod; 2013 Dec; 89(6):150. PubMed ID: 24174578
[TBL] [Abstract][Full Text] [Related]
73. Expression, menstrual cycle-dependent activation, and bimodal mitogenic effect of transforming growth factor-beta1 in human myometrium and leiomyoma.
Arici A; Sozen I
Am J Obstet Gynecol; 2003 Jan; 188(1):76-83. PubMed ID: 12548199
[TBL] [Abstract][Full Text] [Related]
74. Leiomyoma and myometrial gene expression profiles and their responses to gonadotropin-releasing hormone analog therapy.
Luo X; Ding L; Xu J; Williams RS; Chegini N
Endocrinology; 2005 Mar; 146(3):1074-96. PubMed ID: 15604208
[TBL] [Abstract][Full Text] [Related]
75. The Potential of Transforming Growth Factor-beta Inhibitor and Vascular Endothelial Growth Factor Inhibitor as Therapeutic Agents for Uterine Leiomyoma.
Park JY; Chae B; Kim MR
Int J Med Sci; 2022; 19(12):1779-1786. PubMed ID: 36313223
[No Abstract] [Full Text] [Related]
76. Extracellular matrix remodeling and inflammatory pathway in human endometrium: insights from uterine leiomyomas.
Governini L; Marrocco C; Semplici B; Pavone V; Belmonte G; Luisi S; Petraglia F; Luddi A; Piomboni P
Fertil Steril; 2021 Nov; 116(5):1404-1414. PubMed ID: 34256950
[TBL] [Abstract][Full Text] [Related]
77. Sphingosine 1-phosphate signaling in uterine fibroids: implication in activin A pro-fibrotic effect.
Bernacchioni C; Ciarmela P; Vannuzzi V; Greco S; Vannuccini S; Malentacchi F; Pellegrino P; Capezzuoli T; Sorbi F; Cencetti F; Bruni P; Donati C; Petraglia F
Fertil Steril; 2021 Jun; 115(6):1576-1585. PubMed ID: 33500141
[TBL] [Abstract][Full Text] [Related]
78. An endocrine-disrupting chemical, fenvalerate, induces cell cycle progression and collagen type I expression in human uterine leiomyoma and myometrial cells.
Gao X; Yu L; Castro L; Moore AB; Hermon T; Bortner C; Sifre M; Dixon D
Toxicol Lett; 2010 Jul; 196(3):133-41. PubMed ID: 20230880
[TBL] [Abstract][Full Text] [Related]
79. Isolation and characterization of heparin-binding growth factors in human leiomyomas and normal myometrium.
Mangrulkar RS; Ono M; Ishikawa M; Takashima S; Klagsbrun M; Nowak RA
Biol Reprod; 1995 Sep; 53(3):636-46. PubMed ID: 7578688
[TBL] [Abstract][Full Text] [Related]
80. Increased expression of tuberin in human uterine leiomyoma.
Cui L; Ren Y; Yin H; Wang Y; Li D; Liu M; Zhu Y; Lin W; Tang XD; Gui Y; Zheng XL
Fertil Steril; 2011 Apr; 95(5):1805-8. PubMed ID: 21145542
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
